Clorox Company (The) Stock News

Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Clorox (CLX) reported earnings 30 days ago. What's next for the stock?

Investors have flocked to dividend growth stocks since the Federal Reserve began suppressing interest rate via QE. Only 7 stocks likely appeal to investors.

Church & Dwight (CHD) inks an agreement to acquire leading mouthwash brand, TheraBreath. The deal, valued at $580 million, is expected to close in fourth-quarter 2021.

While most everyone in the scientific community suspected that cases of COVID-19 would spike as we got closer to winter in the northern and the eastern parts of the country, similar to the spike in th

Wall Street analysts forecast that The Clorox Company (NYSE:CLX) will announce earnings per share of $0.80 for the current quarter, Zacks reports. Three analysts have made estimates for Cloroxs earnings, with the highest EPS estimate coming in at $0.91 and the lowest estimate coming in at $0.68. Clorox reported earnings of $2.03 per share in []

Wall Street analysts predict that The Clorox Company (NYSE:CLX) will report $1.65 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for Cloroxs earnings, with estimates ranging from $1.62 billion to $1.68 billion. Clorox posted sales of $1.84 billion in the same quarter last year, which []

Stocks sold off sharply on Black Friday with concerns over a new Covid variant adding to macro uncertainties. The potential for new travel restrictions or return of social distancing measures represen

Stocks that traded heavily or had substantial price changes Friday: Delta, Carnival fall; Moderna, Clorox rise

Veracity Capital LLC raised its holdings in The Clorox Company (NYSE:CLX) by 7.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,380 shares of the company’s stock after purchasing an additional 100 shares during the period. Veracity Capital LLC’s […]

Alpha Omega Wealth Management LLC bought a new stake in The Clorox Company (NYSE:CLX) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,610 shares of the company’s stock, valued at approximately $267,000. Several other institutional investors and hedge […]

Asset Management Corp IL ADV grew its stake in The Clorox Company (NYSE:CLX) by 39.4% during the third quarter, HoldingsChannel.com reports. The firm owned 4,540 shares of the companys stock after purchasing an additional 1,283 shares during the period. Asset Management Corp IL ADVs holdings in Clorox were worth $752,000 as of its most recent []

Clorox Company (The) found using ticker (CLX) have now 16 analysts covering the stock. The analyst consensus points to a rating of ''Hold''. The range between the high target price and low target price is between 194 and 131 calculating the mean target price we have 162.03. Given that the stocks previous close was at 166.98 this would imply there is a potential downside of -3.0%. The 50 day MA is 164.52 and the 200 moving average now moves to 176.67. The market cap for the company is $20,593m. Visit the company website at: /> [stock_market_widget type="chart" symbol="CLX" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States.

Marshall Wace LLP decreased its holdings in The Clorox Company (NYSE:CLX) by 20.0% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 8,764 shares of the companys stock after selling 2,192 shares during the quarter. Marshall Wace LLPs holdings in Clorox were worth $1,577,000 at the end of the most recent quarter. A number []

McCollum Christoferson Group LLC reduced its stake in The Clorox Company (NYSE:CLX) by 5.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 12,287 shares of the companys stock after selling 725 shares during the period. McCollum Christoferson Group LLCs holdings in []